CN101677962B - 含有硅酸铝镁的控释片剂制剂 - Google Patents

含有硅酸铝镁的控释片剂制剂 Download PDF

Info

Publication number
CN101677962B
CN101677962B CN2008800156313A CN200880015631A CN101677962B CN 101677962 B CN101677962 B CN 101677962B CN 2008800156313 A CN2008800156313 A CN 2008800156313A CN 200880015631 A CN200880015631 A CN 200880015631A CN 101677962 B CN101677962 B CN 101677962B
Authority
CN
China
Prior art keywords
dosage form
active agent
weight
tablet
aluminum silicate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2008800156313A
Other languages
English (en)
Chinese (zh)
Other versions
CN101677962A (zh
Inventor
P·格勒尼耶
A·尼亚米尔斯
G·维格诺尔特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jagotec AG
Original Assignee
Jagotec AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jagotec AG filed Critical Jagotec AG
Publication of CN101677962A publication Critical patent/CN101677962A/zh
Application granted granted Critical
Publication of CN101677962B publication Critical patent/CN101677962B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Psychology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN2008800156313A 2007-05-17 2008-05-16 含有硅酸铝镁的控释片剂制剂 Expired - Fee Related CN101677962B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0709541.7A GB0709541D0 (en) 2007-05-17 2007-05-17 Pharmaceutical excipient
GB0709541.7 2007-05-17
PCT/IB2008/002128 WO2008142572A2 (en) 2007-05-17 2008-05-16 Controlled release tablet formulation containing magnesium aluminometasilicate

Publications (2)

Publication Number Publication Date
CN101677962A CN101677962A (zh) 2010-03-24
CN101677962B true CN101677962B (zh) 2012-12-12

Family

ID=38234655

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2008800156313A Expired - Fee Related CN101677962B (zh) 2007-05-17 2008-05-16 含有硅酸铝镁的控释片剂制剂

Country Status (9)

Country Link
US (1) US20100196475A1 (enExample)
EP (1) EP2152248A2 (enExample)
JP (1) JP2010527347A (enExample)
CN (1) CN101677962B (enExample)
AU (1) AU2008252481B2 (enExample)
CA (1) CA2684366A1 (enExample)
GB (1) GB0709541D0 (enExample)
IL (1) IL201901A0 (enExample)
WO (1) WO2008142572A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010100414A1 (en) * 2009-03-04 2010-09-10 Orexo Ab Abuse resistant formulation
EA027618B1 (ru) 2009-05-08 2017-08-31 Эмпликюре Аб Композиция для непрерывной доставки лекарственного средства, содержащая геополимерное связующее
MX344141B (es) * 2010-02-26 2016-12-07 Toray Industries Preparacion solida recubierta.
ES2658913T3 (es) 2010-09-07 2018-03-12 Emplicure Ab Dispositivo de administración transdérmica de un fármaco
CN104523627B (zh) * 2014-12-18 2017-04-12 成都苑东生物制药股份有限公司 一种硫酸氢氯吡格雷片药物组合物及其制备方法
US10166185B2 (en) 2015-06-09 2019-01-01 J. Rettenmaier & Söhne Gmbh + Co Kg Excipient and oral solid dosage forms for oily drugs
WO2016201119A1 (en) * 2015-06-09 2016-12-15 J. Rettenmaier & Söhne Gmbh + Co Kg Excipient and oral solid dosage forms for oily drugs
WO2017149287A1 (en) * 2016-02-29 2017-09-08 Emplicure Ab Devices for evaporation and inhalation of active agents
CN105769798A (zh) * 2016-05-16 2016-07-20 张阳 一种高血压治疗药物的制备方法
CN105997915A (zh) * 2016-05-16 2016-10-12 张阳 一种高血压治疗用缓释片剂
GB201714412D0 (en) 2017-09-07 2017-10-25 Emplicure Ab Evaporation devices containing plant material
CN114146061B (zh) * 2020-09-07 2023-06-30 歌礼生物科技（杭州）有限公司 包含固体分散体的蛋白酶抑制剂增效组合物及其制备方法
CN114149011A (zh) * 2020-09-08 2022-03-08 浙江丰虹新材料股份有限公司 一种药用辅料硅酸铝镁及其合成方法
CA3246974A1 (en) * 2022-04-01 2023-10-05 Emplicure Ab Publ ALKALINE INTRAORAL PRODUCTS

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1285655A1 (en) * 2000-04-11 2003-02-26 Sankyo Company, Limited Stabilized pharmaceutical compositions containing calcium channel blockers

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53148519A (en) * 1977-05-31 1978-12-25 Sumitomo Chem Co Ltd Preparation of solid medicine containing gefarnate
JPS58109411A (ja) * 1981-12-23 1983-06-29 Shionogi & Co Ltd ニフエジピン固型製剤組成物
FI20021701L (fi) * 1991-01-30 2002-09-24 Wellcome Found Veteen dispergoituvia tabletteja
DE69727922T2 (de) * 1996-04-16 2005-01-20 Novartis Consumer Health S.A. Schnell zerfallende orale dosierungsform
JPH11286438A (ja) * 1998-03-31 1999-10-19 Shiseido Co Ltd 徐放性製剤
IL143846A0 (en) * 1998-12-23 2002-04-21 Alza Corp Dosage forms comprising porous particles
TW471968B (en) * 1999-08-25 2002-01-11 Committee On Chinese Medicine Solamargine pharmaceutical composition for killing cancer cells
AR030557A1 (es) * 2000-04-14 2003-08-27 Jagotec Ag Una tableta en multicapa de liberacion controlada y metodo de tratamiento
US20030203029A1 (en) * 2001-12-14 2003-10-30 Wong Patrick S.-L. Controlled release liquid active agent formulation dosage forms
IL153277A0 (en) * 2002-12-04 2003-07-06 Pharmos Corp High enantiomeric purity dexanabinol for pharmaceutical compositions
WO2004082679A1 (ja) * 2003-03-17 2004-09-30 Takeda Pharmaceutical Company Limited 放出制御組成物
US20050181049A1 (en) * 2003-11-19 2005-08-18 Dong Liang C. Composition and method for enhancing bioavailability
CA2547657A1 (en) * 2003-12-01 2005-06-16 Lifecycle Pharma A/S Pharmaceutical compositions comprising lercanidipine
WO2005123040A1 (ja) * 2004-06-22 2005-12-29 Shionogi & Co., Ltd. 口腔内速崩壊錠
AU2005256322C1 (en) * 2004-06-28 2011-07-07 Veloxis Pharmaceuticals, Inc. Porous tablets as carriers for liquid formulations
CA2577583A1 (en) * 2004-08-19 2006-03-02 Alza Corporation Controlled release nanoparticle active agent formulation dosage forms and methods
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
WO2006082523A2 (en) * 2005-01-25 2006-08-10 Aurobindo Pharma Limited Pharmaceutical sustained release composition of metformin

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1285655A1 (en) * 2000-04-11 2003-02-26 Sankyo Company, Limited Stabilized pharmaceutical compositions containing calcium channel blockers

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Mcginity J.W., et al.Optimization of slow release tablet formulations containing montmorillonite I. properties of tablets.《Drug Development and Industrial Pharmacy》.1980,第6卷(第4期),339-410. *
Puttipipatkhachorn S.,et al.Molecular interaction in alginate beads reinforced with sodium starch glucolate or magnesium aluminum silicate, and their plhysical characteristics.《International Journal of Pharmaceutics》.2005,第293卷(第1-2期),51-62. *

Also Published As

Publication number Publication date
JP2010527347A (ja) 2010-08-12
AU2008252481A1 (en) 2008-11-27
US20100196475A1 (en) 2010-08-05
CN101677962A (zh) 2010-03-24
EP2152248A2 (en) 2010-02-17
IL201901A0 (en) 2010-06-16
WO2008142572A2 (en) 2008-11-27
AU2008252481B2 (en) 2014-05-01
CA2684366A1 (en) 2008-11-27
WO2008142572A3 (en) 2009-02-12
GB0709541D0 (en) 2007-06-27

Similar Documents

Publication Publication Date Title
CN101677962B (zh) 含有硅酸铝镁的控释片剂制剂
AU2007280471B2 (en) Multilayer orally disintegrating tablet
EP1555022B1 (en) Sustained release formulation of acetaminophen and tramadol
JP3251190B2 (ja) 体液と接触することにより容積が高度に増加する薬学的圧縮錠剤
EP1272167B1 (en) Ropinirole-containing hydrophilic/liphilic polymeric matrix dosage formulation
CA2904045C (en) Benzonatate modified release solid tablets and capsules
CA2720108A1 (en) Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
US20100092557A1 (en) Dosage Form Comprising Immediate Release Naproxen and Sustained Release Opioid Analgesic
US20050281875A1 (en) Promethazine containing dosage form
US20100291209A1 (en) Organic compounds
JP5059611B2 (ja) 正確な用量分割機能を有する製剤
US10098856B2 (en) Alternating sympathomimetic therapy for the treatment of respiratory ailments
EP2046300B1 (en) Multilayer orally disintegrating tablet
US11938224B1 (en) Benzonatate modified release solid tablets and capsules
US20200222329A1 (en) Abuse deterrent oral solid dosage form
HK1128881B (en) Multilayer orally disintegrating tablet
Gaurav Preparation and evaluation of mucoadhesive buccal sustained release dosage form of nsaids using hydrotalcite

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20121212

Termination date: 20160516